Inmune Bio Inc (NQ: INMB )
6.620
-0.240
(-3.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Inmune Bio Inc
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2023/11/A1-112023-alzheimers-jkrause.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For INmune Bio
August 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
INmune Bio's Earnings Outlook
May 02, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
INmune Bio Earnings Perspective: Return On Capital Employed
March 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Preview: INmune Bio
March 01, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
From INmune Bio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/13/screenshot_2023-06-13_at_6.18.21_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
![](https://ml.globenewswire.com/media/4e9d613a-fd5b-43ca-b4dc-efa510cac7f7/small/inmunebio-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.